Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Conference abstract · 2018 Conference abstract · 2018 The study of association between serum brain derived neurotrophic factor protein and dyslipidemia on memory performance in Thai Alzheimer disease patients
this study is to investigate the association between serum BDNF protein and dyslipidemia on memory performance in Thai Alzheimer Disease (AD) patients. After this research project has been certified
Conference abstract · 13 Sep 2017 “Reappraise the Association of Dyslipidemia and CVD Risk in T2DM: How to Optimize Statin Therapy from the International Guideline Perspective”
cause of mortality in patients with diabetes. Whilst there are many potential mechanisms including dyslipidemia, hypertension, inflammation and increased oxidative stress, low density lipoprotein-…
Conference abstract · 14 Nov 2016 Efficacy and Safety of a Nutritional Supplement Combination on Dyslipidemia and Cardiovascular Inflammatory Markers
safe alternative to statins and other lipid- lowering drugs in the treatment of dyslipidemia
Conference abstract · 2015 Impact of clinical pharmacist counselling on disease outcome parameters and quality of life on uncontrolled Hypertensive Diabetic Dyslipidemia
Hypertension and dyslipidemia are main complications of Diabetes. Hypertension prevalence 28.7% in US ,Diabetes prevalence 7%,while prevalence of Diabetes in SA 27% and HTN 26%.Clincal pharmacist is health
Brief report · 29 Oct 2025 Evolving Dyslipidemia Management: Drugs, Lifestyle, Genetics
Commentary · 30 Jun 2025 Dyslipidemia and Its Role in the Development of Heart Disease, Stroke and Metabolic Disorders
Editorial · 31 Mar 2025 Understanding Dyslipidemia: Causes, Risks, and Management
Research article · 22 Jan 2025 Differences and factors associated with dyslipidemias in American adolescents of Hispanic and Asian Indian descent.
triglyceride, and high-density lipoprotein were categorized as acceptable, borderline, high, or as combined dyslipidemia by stages of adolescence of early, middle, and late and sex-age based percentile ... overweight…
Perspective · 30 Oct 2024 Pediatric Dyslipidemia: Evaluating the Use of Statins in Children
Editorial · 30 Sep 2024 Mechanisms of Endothelial Dysfunction: The Role of the Renin- Angiotensin Axis, Oxidized LDL, Insulin Resistance, Dyslipidemia, Hyperglycemia, Inflammatory Cytokines, and Autoimmunity
endothelial impairment, including the renin-angiotensin axis, oxidized low-density lipoproteins (oxLDL), insulin resistance, dyslipidemia, and hyperglycemia. Additionally, we examine the impact of pro-inflammatory…
Perspective · 30 Sep 2024 Mechanisms of Endothelial Dysfunction: The Role of the Renin- Angiotensin Axis, Oxidized LDL, Insulin Resistance, Dyslipidemia, Hyperglycemia, Inflammatory Cytokines, and Autoimmunity.
Homocysteine, an amino acid in the blood, has been implicated in various
Article · 27 Dec 2023 Managing dyslipidemia in type 2 diabetes mellitus: A comprehensive approach
Opinion · 18 Dec 2023 Endocrine Diseases Associated with Dyslipidemia
Short communication · 28 Jul 2023 Utilizing nutraceuticals with lipid-lowering properties for an integrative strategy in managing dyslipidemia
Dyslipidemia, a modifiable risk factor for atherosclerotic cardiovascular disease, can be effectively addressed through lifestyle modifications and/or lipid-lowering therapies. However, the clinical use of statins may…
Short communication · 27 Jul 2023 Dyslipidemia-Induced Cellular Senescence in Atherosclerosis: Mechanisms and Therapeutic Implications
Opinion · 28 Feb 2023 Hyperglycemia, Dyslipidemia and Cardiovascular Risk Factors of Pcos Rats
Research article · 3 Jan 2023 Dyslipidemia in Hyperuricemia Patients: A Hospital Based Study
matched healthy 50 individuals. The present study was done to determine the extent of dyslipidemia in hyperuricemic patients. Association of dyslipidemia and hyperuricemia has been the long interest of researchers…
Perspective · 26 Dec 2022 Current Administration Methodologies: Atherogenic Dyslipidemia in Diabetes
Conference abstract · 22 Nov 2022 Role of enterocytes in dyslipidemia of type 2 diabetes
with increased cardiovascular risk. Current evidence points out a leading role of enterocyte in dyslipidemia of type 2 diabetes mellitus, since it increases the production of apolipoprotein

